BEVERLY, Mass. -- HighRes® today announced a strategic collaboration to enable robotic capabilities on Waters Biosciences, formerly BD Biosciences, flow cytometers to automate key experimental steps and streamline research workflows, from basic research to drug discovery. The companies are integrating the BD FACSLyric™ Flow Cytometer1 with the HighRes Nucleus® Automation and Cellario® Software Platforms, enabling [...]

New capabilities connect AI agents, scientific literature, and validated computational engines to accelerate model-informed drug development RESEARCH TRIANGLE PARK, N.C. -- Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that helps advance biopharma innovation, today announced it is building the agentic layer of Composer, [...]

Cellario OS™ is the open, instrument-agnostic execution layer that turns experiments from any AI Scientist into validated, provenance-rich laboratory data, completing the loop between AI-driven hypothesis and real-world result. BEVERLY, Mass. -- HighRes® today announced that its Cellario OS™ lab orchestration platform serves as the open execution layer for AI Scientists, both autonomous agents and AI-enabled [...]

Applications include structure research and operando studies of new materials for manganese-rich, sodium-ion, and all-solid-state batteries. CRANS-MONTANA, Switzerland – Bruker today at the EPDIC 2026 announced the launch of the D8 ADVANCE HE and D8 DISCOVER HE, new X-ray diffraction systems specifically optimized for High-Energy X-Ray Diffraction (HE-XRD), expanding the ability of researchers to capture higher real-space resolution, extended [...]

CALGARY, AB -- Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, FRA: 1N1), a leader in portable NMR spectrometers and imaging technology for industrial and research applications, announces a series of strategic developments, including a quantum technology partnership with NVision Quantum Technologies GmbH ("NVision"), an expanded collaboration with IMRIS, government funding support, contract wins within its [...]

The companies will generate data using Applied StemCell’s induced pluripotent stem cell technologies and Syntax Bio’s Cellgorithm™ platform to support application discovery and development CHICAGO & MILPITAS, Calif. -- Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), a leader in induced pluripotent stem cell (iPSC) [...]

CHICAGO and ITASCA, Ill. – Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture innovation and part of Ajinomoto Group, today announced a collaboration to evaluate Ajinomoto Group’s StemFit™ stem cell culture products using [...]

New funding will power foundational primary cell data generation to advance AI-driven discovery through the company's full product launch. MONTREAL and BOSTON -- DropGenie, a biotechnology company advancing next-generation gene editing workflows, today announced the closing of its Seed+ financing to support the launch of its first product. The round was led by Skeleton Key, [...]

Scientists can now search, understand and act on complex R&D data in natural language by leveraging leading LLM capabilities within the Signals One platform Governed data and ontology-driven scientific context support reliable, traceable results across workflows Native agentic framework turns connected data and knowledge into task-ready insights for scientists WALTHAM, Mass. -- Revvity, Inc. (NYSE: RVTY) [...]

Built into Uncountable's platform, Bodie searches, analyzes, and acts on data across the full R&D lifecycle, from discovery to quality control Meet Bodie | Videos & Movies on Vimeo SAN FRANCISCO – Uncountable, a software company that develops AI-powered platforms for end-to-end product development, today announced the launch of Bodie, a new AI assistant integrated [...]